@ashenafi-a.bsky.social
Seminar at the Ethiopian Public Health Institute (EPHI)
@ideel.bsky.social
@ideel.bsky.social
April 23, 2025 at 2:38 PM
Seminar at the Ethiopian Public Health Institute (EPHI)
@ideel.bsky.social
@ideel.bsky.social
Our new article: "Increasing day three parasitaemia...
SW Ethiopia" TES. This is a relevant given the increasing reports of partial ACT resistance markers in E/Africa. @ideel.bsky.social
doi.org/10.1186/s129...
SW Ethiopia" TES. This is a relevant given the increasing reports of partial ACT resistance markers in E/Africa. @ideel.bsky.social
doi.org/10.1186/s129...
Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria ...
Background Since 2017, the first-line treatment for uncomplicated Plasmodium falciparum infection in Ethiopia has been artemether-lumefantrine (AL), plus a single dose of primaquine (PQ). The World He...
doi.org
March 19, 2025 at 9:33 PM
Our new article: "Increasing day three parasitaemia...
SW Ethiopia" TES. This is a relevant given the increasing reports of partial ACT resistance markers in E/Africa. @ideel.bsky.social
doi.org/10.1186/s129...
SW Ethiopia" TES. This is a relevant given the increasing reports of partial ACT resistance markers in E/Africa. @ideel.bsky.social
doi.org/10.1186/s129...
A two-day national consultation is taking place in Addis Ababa to discuss the challenges of the current malaria resurgence. High-level officials from the Ministry of Health, EPHI, AHRI, academia, and other stakeholders are in attendance.
February 18, 2025 at 6:30 PM
A two-day national consultation is taking place in Addis Ababa to discuss the challenges of the current malaria resurgence. High-level officials from the Ministry of Health, EPHI, AHRI, academia, and other stakeholders are in attendance.